<p>Alison Friedmann, MD, M.SC is the Clinical Director of the Pediatric Hematology/Oncology Unit at the Mass General Hospital for Children. She received a Bachelor of Science degree from University of California, Berkeley, and her medical degree from Dartmouth Medical School. She completed a pediatrics residency at Dartmouth-Hitchcock Medical Center and her hematology/oncology fellowship at Johns Hopkins Hospital. Dr. Friedmann is board certified in both Pediatrics and Pediatric Hematology/Oncology. She has cared for children with cancer and blood disorders for more than twenty years. As a faculty member at MGH since 1998, she has focused on clinical care, clinical research, and teaching. Dr. Friedmann leads the Pediatric Chemotherapy Safety Committee, serves as Quality and Safety Champion, and is a member of the Dana Farber/Harvard Cancer Center Pediatric Scientific Review Committee. She has published many scholarly articles and book chapters. Her primary research interests are in supportive care, soft tissue sarcoma, leukemia, and lymphoma. She was a national coordinator of a Children’s Oncology Group (COG) trial for standard risk acute lymphoblastic leukemia, and serves as the MGH principal investigator for COG. She has been recognized with awards for both her clinical excellence and compassionate care, including Alpha Omega Alpha, the Alma Hass Milham Award for Humane and Ethical Values, the MGH Cancer Center One Hundred Award, and “Top Doc” in Pediatrics by Boston Magazine. Dr. Friedmann has had a long-standing relationship with Camp Sunshine, a retreat for children and families with serious illnesses, serving as camp physician during their summer program for many years and on their medical board. A mother of three children herself, she is passionate about caring for young people and improving their outcomes and quality of life.</p>